Medication errors with electronic prescribing (eP): Two views of the same picture by Savage, Imogen et al.
Savage et al. BMC Health Services Research 2010, 10:135
http://www.biomedcentral.com/1472-6963/10/135
Open Access RESEARCH ARTICLE
© 2010 Savage et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.
Research article Medication errors with electronic prescribing (eP): 
Two views of the same picture
Imogen Savage*1, Tony Cornford2, Ela Klecun2, Nick Barber1, Sarah Clifford1 and Bryony Dean Franklin1,3
Abstract
Background: Quantitative prospective methods are widely used to evaluate the impact of new technologies such as 
electronic prescribing (eP) on medication errors. However, they are labour-intensive and it is not always feasible to 
obtain pre-intervention data. Our objective was to compare the eP medication error picture obtained with 
retrospective quantitative and qualitative methods.
Methods: The study was carried out at one English district general hospital approximately two years after 
implementation of an integrated electronic prescribing, administration and records system. Quantitative: A structured 
retrospective analysis was carried out of clinical records and medication orders for 75 randomly selected patients 
admitted to three wards (medicine, surgery and paediatrics) six months after eP implementation. Qualitative: Eight 
doctors, 6 nurses, 8 pharmacy staff and 4 other staff at senior, middle and junior grades, and 19 adult patients on acute 
surgical and medical wards were interviewed. Staff interviews explored experiences of developing and working with 
the system; patient interviews focused on experiences of medicine prescribing and administration on the ward. 
Interview transcripts were searched systematically for accounts of medication incidents. A classification scheme was 
developed and applied to the errors identified in the records review.
Results: The two approaches produced similar pictures of the drug use process. Interviews identified types of error 
identified in the retrospective notes review plus two eP-specific errors which were not detected by record review. 
Interview data took less time to collect than record review, and provided rich data on the prescribing process, and 
reasons for delays or non-administration of medicines, including "once only" orders and "as required" medicines.
Conclusions: The qualitative approach provided more understanding of processes, and some insights into why 
medication errors can happen. The method is cost-effective and could be used to supplement information from 
anonymous error reporting schemes.
Background
Replacing inpatient paper medication orders and medical
notes with electronic records is widely seen as the key
step to improve patient safety both in the United King-
dom [1-3] and elsewhere [4]. Most UK hospital trusts are
reported [1] to think that computerisation will reduce
medication errors by increasing control over prescribing.
However, very few UK hospitals [5,6] have actually imple-
mented hospital-wide electronic systems for ordering
and recording administration of medicines (both defined
as electronic prescribing in the UK). A similar, though
slightly better, situation has been reported in Norway [7]
with implementation in most hospitals "stalled". In the
USA, widely perceived as leading the field in hospital
computerised prescribing, less than 10% of hospitals are
reported [8] to have electronic systems.
This is not really surprising as information and com-
munication technology systems are complex and costly
interventions. Committing to a particular system
requires belief in the evidence that it will be better than
current practice, and that potential problems can be
managed [9]. Such evidence usually comes from evalua-
tion studies.
The majority of research studies testing the effect of
interventions on medication prescribing error rates have
used prospective process (observational error counting)
or outcome (harm recording) methods [10]. Prospective
detection of unintended injury caused by medical man-
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agement has higher face validity than retrospective meth-
ods [11]. For medication errors [12-14] the advantage of
prospective methodology is that it allows some or all of
the data collection to be done as part of a pharmacist's
normal prescription (order) monitoring duties, so reduc-
ing research staff workload and cost. The drawback is
that if- as frequently happens- an evaluation is commis-
sioned quite close to the time of implementation, it may
not be possible for the evaluators to obtain access to the
site before the intervention is put in place. In such cases,
the only option is to gather pre-intervention data retro-
spectively, an approach which has been little used in the
UK [10,15].
To date, retrospective eP evaluations have involved car-
rying out a structured clinical review of a sample of
patient medical records to identify, classify and count dif-
ferent types of medication errors. However, the people
providing or receiving hospital care also offer a rich
s o u r c e  o f  d a t a  o n  t h e  d a y -t o - d a y  w o r k i n g s  o f  a  n ew l y
implemented eP system. Interviews with stakeholders
have already been used to understand the ways such a
system can be introduced into, and become part of, hos-
pital practice [15,16].
The aim of this study is to compare the post-eP error
pictures provided by retrospective record review and by
interviews with staff and patients within one hospital,
and to consider the usefulness of interviews as an evalua-
tion method.
Methods
This retrospective evaluation was approved by the South
East Staffordshire local research ethics committee
(LREC) and conducted at Queen's Hospital Burton upon
Trent [QHB]. This district general hospital was an early
adopter of eP and has a long-established system [15]
operating as part of a Meditech hospital-wide informa-
tion system (HIS) and linked to all other electronic
patient and laboratory data. Traditional paper medical
notes were maintained but all other records were made
and stored electronically. Wireless laptops and static ter-
minals allowed access from almost anywhere in the hos-
pital site. Senior staff could also access the system from
home.
All authorised staff had access to patient care records;
pharmacists used the system to carry out daily prescrip-
tion review of their allotted patients. System entry was via
personal identification number (PIN) and password,
issued after mandatory in-house training. All activities
were fully auditable.
QHB had a clear policy on eP decision support: the pre-
scriber remained responsible for the decision and hence
most of the support was ensuring that drugs prescribed
were on the hospital formulary, in doses and formulations
that could be supplied. The eP system had been cust-
o m i s e d  t o  g i v e  p r e s c r i b e r  " r e d  b o x "  w a r n i n g s  o n l y  f o r
clinically significant drug-drug interactions, as defined in
the British National Formulary. These could be over-rid-
den if the prescriber wished, Default doses, dosing fre-
quencies and maximum dose warnings were only set for
specific drugs when the consensus was that these would
be useful. Drug-allergy and drug-laboratory tests (eg:
renal function; INR) checks were not activated.
Implementation began in late 1996 and by 2002, elec-
tronic prescribing and administration of medications was
the norm on all NHS wards, with paper charts reserved
for drugs with highly variable regimens (eg: insulin).
Our data collection began approximately two years
after eP rollout was complete. Initial contact with the
hospital was made through the head of pharmacy ser-
vices who then provided information about the study to
potential participants. Verbal informed consent was
obtained and documented for all interviewees; patients
were also given an information leaflet. The LREC did not
require patient consent for the retrospective record
review.
Record review data
Patients were sampled from three wards (general medi-
cine; general surgery; paediatrics) which had different
versions of the Meditech software introduced at different
times between 1999 and 2002. For each ward, data were
collected for 25 randomly selected patients admitted in
the calendar month six months before implementation of
eP and for 25 patients admitted in the calendar month six
months afterwards. Only post-eP data will be presented
in this paper. Patients were identified from the HIS and
all electronic and paper records retrieved.
One research pharmacist carried out a structured
review of all medication orders and laboratory tests for
each patient throughout his or her stay on the ward. The
total number of medication orders written was also
recorded. An electronic retrospective review form (RRF)
adapted from that used in the first UK study of iatrogenic
injury [17] was used to capture data for each patient
reviewed, and to classify errors according to published
criteria [18]. A short text description providing informa-
tion on the drug, dose and clinical situation was recorded
for each error identified.
Interview data
Pharmacy staff and the majority of senior clinicians were
identified and approached by a senior hospital manager.
Other clinical and ward staff were recruited by senior
pharmacists responsible for the relevant wards or identi-
fied by the research team during interviews and depart-
ment visits. A staff announcement was also put out on
the HIS.Savage et al. BMC Health Services Research 2010, 10:135
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Twenty-six staff (8 doctors, 6 nurses, 8 pharmacists/
technicians and 4 others) at senior, middle and junior
grades, and 19 adult in-patients were interviewed. All
staff participants used the HIS as part of their work. The
majority of interviews were tape-recorded. If recording
was not feasible (because of the setting), written notes
were made.
The interview topic guide [15] was developed from ini-
tial interviews with four members of the implementation
team and three users (prescribers). There were no direct
questions about medication errors. All staff interviews
explored stakeholder views of key benefits and problems,
and influences on working practices. Questions were tai-
lored to the respondent's professional group.
Adult patients were recruited from all general surgery
and acute medicine wards in the hospital, including the
two wards used in the record review. Recruiting children
was not attempted. Nineteen men and women aged 26 to
over 70 took part. Sampling was purposive, based on use
of "as required" medication and previous admission his-
tory. Using Meditech, a senior pharmacist generated a
paper listing of eligible patients for each ward. The
researchers then checked with the ward sister to deter-
mine if pa tients wer e a vaila ble, and we ll enough t o be
approached. Interviews were shorter than for staff and
focused on the system for prescribing and administering
medicines on the ward [15]. We asked specific questions
about missed or refused doses, access to medicines out-
side normal drug round times, and discharge medication.
Data analysis
The text descriptions of errors found in the retrospective
record review were entered into the database by the
research pharmacist and reviewed by BDF.
Interview data were collected and analysed by TC, EK,
IS and SC. Transcripts and notes were read indepen-
dently, then emerging themes discussed and agreed.
Interview transcripts were then searched systematically
for accounts of medication incidents, both actual and
hypothetical. A classification scheme based on the stage
of the medicine use process was developed through itera-
tive review of individual reports [19] and then applied to
the text descriptions of errors identified in the records
review.
The manpower required to collect data for each
approach was estimated from staff diaries at the end of
the study.
Results
The record review database included 85 individual
descriptions of prescribing and administration errors,
Three of these (one drug-drug interaction and two fail-
ures to adjust dose in renal impairment) resulted in harm
[15].
Seventeen of the 26 staff interviews contained 69
accounts of possible medication errors. One of these
accounts concerned fluid overload with intravenous ther-
apy and had serious consequences. Three of the 19
patient interviews also contained error accounts. Nine
staff did not describe possible medication errors. Four of
them had no direct involvement with medication, three
were nurses, and two were senior members of the original
implementation team.
Figure 1 shows the classification scheme developed
from the staff interviews. Table 1 presents the types of
error described by different respondent groups. Table 2
compares the types of error identified using interviews
and with record review.
Details of specific errors identified are set out below,
ordered under the headings used in Figure 1. This scheme
follows the drug use process from the decision to pre-
scribe through to administering, recording and monitor-
ing the effects of medication, and reflects the way that
subjects "talked through the screens" as they explained
how they used the eP system.
eP interface errors
A t  Q H B ,  t h e  v a s t  m a j o r i t y  o f  c l i n i c a l  i n f o r m a t i o n  w as
available electronically through the HIS. Outside the hos-
pital, the situation was different. Patients admitted to and
discharged from wards using eP therefore moved across
an interface between a mostly paper-free and mostly
paper-based world. As they moved, errors could occur.
One staff interview described a case where medicines
had been omitted from a patient's prescription on admis-
sion. The patient had been in hospital for two months
before she told the pharmacist that she normally used
eye-drops at home. A patient recounted a similar inci-
dent. In another interview, a junior doctor spoke of a dia-
betic patient who had been discharged to a care home
with no insulin because the prescriber had not put a note
on the eP system to prescribe this on discharge. Record
review found three cases where medication (salbutamol,
amitriptyline, insulin) had not been continued as
expected when the patient moved between health care
sectors. This could happen because medication required
for discharge had to be flagged on the system by the pre-
scriber, then "converted" from inpatient orders in the
pharmacy before dispensing.
Errors at the prescribing stage
Clinical need
Record review provided a wide range of examples where
the need for treatment, review or investigation had not
been met. Cases included antibiotic therapy for methicil-
lin-resistant Staphylococcus aureus not being prescribed;
lack of potassium supplementation in a hypokalaemic
asthmatic; not reviewing fluoxetine treatment whenSavage et al. BMC Health Services Research 2010, 10:135
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Figure 1 Error classification scheme developed from staff interviews.
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Patient’s current medicines entered into the eP 
system
Prescribing the medicine (doctors)
Prescriber assesses clinical need for medication
Selects patient record from eP menu
Decides which drug(s) to prescribe 
Picks drug name, strength and formulation (eg: tablet, 
liquid, injection....) from menu
Enters dose to be given (as strength, eg: 500mg or as 
number of units, eg: “2 tablets”)
Enters frequency (eg: give now; give if needed; give 
regularly three times a day)
May also give instructions for length of treatment; 
quantity to supply 
Supplying the medicine (pharmacy staff)
Dispensing of ward stock items and  individual patient 
medication 
Administering the medicine (nurses)
Nurse selects patient record
Administers and records regular drugs due at that time
Administers  and records “when required” medicines
Administers and records  “once only” drugs
Monitoring the effects (doctors, nurses, 
pharmacists)
Make and record clinical observations
Order and assess laboratory tests
Observe and record drug-related problems
Order and assess drug plasma levels
eP interface: Patient is discharged home; to 
another hospital; or moves to theatre or ICU 
Prescriber assesses clinical need for medication
Prescribes medicines (as above) “to take home”
Current medication reported for paper-based 
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hyponatraemia was reported; and untreated hyperlipi-
daemia. Interviews provided only two examples: neglect-
ing to prescribe antibiotics for a patient with heart valve
disease and an account from a patient who reported not
being able to get the hospital doctors to prescribe her
usual migraine medication.
Patient selection
A pharmacy interview described a case where medicines
had been prescribed for the wrong patient because of a
scrolling error on the patient selection screen. Junior doc-
tors also described near-misses, and said that this error
could happen "because you are not going to the bedside".
No cases of prescribing to the wrong patient were
detected in the record review
Drug choice
Both methods identified knowledge-based errors. In
record reviews these included potentially clinically signif-
icant drug interactions involving aminophylline and phe-
nytoin; use of digoxin and acitretin in renal impairment;
and prescribing a penicillin to a patient recorded as possi-
bly allergic. Interviews with doctors mentioned lack of
penicillin allergy warnings, and also prescribing a non-
steroidal analgesic drug which was "hidden" in a post-
operative "order set" to an asthmatic patient. However
there were no accounts of drug-drug interactions.
Menu picking
The eP prescribing (order entry) screen had "look-up"
functions for drug names, doses and routes, and links to
drug monographs and local guidelines and policies. In
Table 1: Number of accounts of different types of medication errors described in staff and patient interviews.
Data source eP interface Prescribing Supply Administration Monitoring
Doctors (7) 11 90 8 5
Nurses (3) 03071
Pharmacy staff 
(7)
41 51 4 1
Patients (3) 11010
TOTAL 63 812 07
Table 2: Medication errors identified using interviews and record review.
Type of medication error Was error identified using this method?
Record review Interview
eP interface yes yes
Prescribing
Clinical need yes yes
Patient record selection no yes
Drug choice yes yes
Menu picking no yes
Dose, form and dosing frequency yes yes
Drug/dose duplication yes yes
Supplying yes yes
Administering
Dose omission (regular medication) yes yes
Dose omission (once only or if required) no yes
Recording of administered dose yes yes
Monitoring yes yesSavage et al. BMC Health Services Research 2010, 10:135
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record review it was not possible to say whether picking
the wrong drug or strength was purely a scrolling error, or
if the prescriber did not know what the correct choice
should be. However, pharmacy staff describing cases
where doctors had ordered the next drug on the lookup
menu considered it very unlikely that this would have
happened if the prescription had been hand-written as
the drugs (methotrexate instead of methotrimeprazine;
ethamsylate instead of ethambutol) were so very differ-
ent.
Drug/dose duplication
Both methods identified unintentional drug duplication
(eg: prescribing paracetamol, and a paracetamol-contain-
ing combination product) and dose duplication, where a
drug (eg: an analgesic or anti-emetic) was prescribed
orally and by other routes to allow nurses flexibility
depending on the patient condition but the maximum
daily dose for the drug was not specified.
Dose, form and frequency
Wrong doses, product strengths and dosing frequencies
were identified in both interviews and notes review.
However interviews primarily cited warfarin and special-
ist paediatric drugs while errors identified in reviews
involved different paediatric and anticoagulant drugs,
plus anti-epileptics. Dose frequency errors often involved
the lack of a daily limit on "as required" analgesics and
anti-emetics, reflecting the inflexibility of eP for this type
of drug order. Interviews generated two examples of pos-
sible dosing frequency errors: a once-weekly drug pre-
scribed once a day, and drugs for Parkinson's disease.
Formulation selection errors mainly involved enteric
coated products.
Supply and administration errors
New orders for drugs not carried as ward stock were
picked up by the pharmacy system. Review of administra-
tion records identified several regular drugs (including
antibiotics and anti-epileptics) which had not been given
because no supply was available on the ward. One phar-
macy technician described how an incorrect strength of
an unidentified drug had been issued as "ward stock". The
error had been detected by a nurse during a drug round.
There were no accounts of scrolling errors when nurses
selected patient names from the screen during drug
rounds.
Dose omission
The patient drug administration screen listed all regular
medication before as required and once-only orders. In
interviews, junior doctors and nurses mentioned that
urgent once-only orders (eg intravenous furosemide) and
some as-required medicines were not given because they
"fell off the screen" ie could not be seen without "paging
down". One patient complained that her once-only dose
of an IV antibiotic was several hours overdue. Record
review did not identify any errors of this type. We also
found some patients who didn't know that they had been
prescribed as-required drugs that they could have asked
for if needed. Retrospective record review could not iden-
tify errors with this type of drug order as it was impossi-
ble to know if need had in fact existed.
Scheduling of doses was done at the point of prescrib-
ing. Regular medicines were allocated times correspond-
ing to ward drug rounds, with a 2-hour window to allow
for variation. Junior doctors and nurses described how
default timings in the eP dose scheduling system could
delay the start of a new regular medication. Pharmacists
and doctors also described difficulties with flexibly dosed
drugs such as warfarin and insulin, which required paper
records.
Recording and monitoring errors
eP recording
The risk of dose duplication when eP records were not
available was identified in both interviews and record
review. Nurse and doctor interviews described being
unsure, when the system was down, if a patient asking for
analgesia had recently received a dose. There was also a
report that analgesic doses given in theatre (which did
not use eP) might be repeated on the ward. Record review
found cases where analgesics and propranolol had been
prescribed as regular drugs, but no administration
records had been made so it was not clear whether or not
they had been given.
Two interviews described cases where medication (top-
icals and IV fluids) had been given but had not been pre-
scribed on the system and so an eP administration record
could not be made. Record review identified several cases
where oxygen had been given but not prescribed.
Monitoring
Record review identified errors involving lack of renal
function monitoring for patients prescribed digoxin, and
lack of aminophylline and phenytoin plasma level mea-
surement for patients co-prescribed clarithromycin.
Interviews generated possible incidents where warfarin
and gentamicin doses had not been adjusted on the basis
of test results (eg with warfarin, gentamicin, sliding scale
insulin), or where physiological monitoring had not been
done (intravenous fluids)
Research resources comparison
From initial scoping visit to final interview, collecting
data for this study took 14 months. Record review: On
average, only four patients could be reviewed each day.
Despite most records being electronic, retrieving patient
information was not particularly quick as there were
problems accessing the optical disk archive at busy times.
Reviewing 75 patients took approximately 20 researcher-
days.Savage et al. BMC Health Services Research 2010, 10:135
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Interviews
The 26 staff interviews took approximately 11 researcher-
days, with the majority (19) conducted by three research-
ers over three consecutive days. Patients were recruited
and interviewed by two researchers over a second three-
day period.
Both record review and interview datasets required fur-
ther work after collection. Unfortunately diary informa-
tion was not available for all researchers involved so we
were unable to make a comparison.
Discussion
Our classification of the prescribing process is an over-
simplification, developed from the way the staff partici-
pants described how they worked. The actual prescribing
process is probably much less linear as each step may
need to draw on knowledge of previous events (medi-
cines, diagnoses, tests, observations) recorded in patients'
charts and notes. The interview sample size was method-
ologically adequate [19] but the relatively small number
of records reviewed was a pragmatic choice, based on
previous experience [15]. By its nature, record review is
more likely to identify errors of omission than an inter-
view.
Despite these limitations, record review and interviews
produced similar pictures of medication errors, although
interviewees often described hypothetical incidents with-
out mentioning the specific drugs involved. The three
drugs they mentioned most often were warfarin, insulin
and intravenous fluids. This is probably because these
variable dose medicines were less straightforward to pre-
scribe, with or without eP.
In interviews, the types of incident described reflected
the respondent's role. Junior doctors (who do most of the
prescribing) and pharmacy staff (who supply the drugs
and review most of the orders) described the widest
range of incidents. Nurses focused on drug administra-
tion and were generally cautious in their responses. All
three professional groups had been involved in system
development, but nurses were clearly the most concerned
about personal accountability [20,21]. Some patients were
also concerned about sounding negative, despite assur-
ances that what they told the interviewer would not affect
their future care.
The majority of incidents described by staff were close
analogies of those that also happen with paper charts. In
interviews the inability to "see the whole picture" on the
screen appeared to be mainly a problem for those rela-
tively new to the system, but much less of a problem than
in the recent USA study [8].
The general view is that eP will reduce errors but new
technology can also introduce new types of error
[8,13,22]. Two of the three serious post-eP errors
described by Shulman et al [22] were "menu picking"
errors. Our retrospective review did not detect these eP-
specific errors but, significantly, our interview data did. It
also provided rich detail on the technical work [23] of
prescribing and administering drugs on the wards.
Robust evaluations are vital tools for persuading users
to adopt new technologies, but prospective before-after
data collection can take 18 months. This time may not be
available, particularly if the evaluation is commissioned
around the time of implementation. This can weaken the
impact of the findings. The evaluation report [24] of the
three pilot sites for the proposed NHS Electronic Health
Record (EHR) noted that the study was "seriously ham-
pered" by the failure to build in evaluation before the
EHR project started.
The retrospective record review reported here was
quicker than the prospective evaluation we did at a differ-
e n t  s i t e  [ 1 2 ]  b u t  r e c o r d  d a t a  c o l l e c t i o n  t o o k  m o r e
researcher-days than interview data. Interviews tailored
to address policy-makers' questions could therefore offer
good research value particularly if the study site is remote
from the research contractors' usual workplace.
Evaluation increases our understanding of the influence
of technologies on working practices and patient out-
comes, including occurrences of medication errors, but
qualitative data on staff perception of errors has been
claimed to provide weaker evidence than counts of actual
errors [25]. Counts provide error frequencies which are
good for efficacy testing but we suggest that counting is
not the only way. We need to explore how people change
and are changed by systems [7] and use beliefs about
errors [8] to maintain and develop safe and effective
healthcare working practices.
For example, pharmacists using eP may believe that
ready access to a wide variety of computerised results
improves their ability to trap prescribing errors, but it
may also reduce face-to-face contact with staff and
patients because they no longer need to visit the wards to
get the clinical information they need for effective pre-
scription review. This change in practice could have a sig-
nificant effect on inter-professional communication; it
might also change the pattern of errors that pharmacists
miss.
Conclusions
Medication error is a sensitive subject, and people may
have concerns about reporting actual errors. In our staff
interviews, talking about the perceived benefits and
drawbacks of their hospital eP system generated many
accounts of specific errors which "could" or "might" hap-
p e n ,  a s  w e l l  a s  d e s c r i p t i o n s  o f  n e a r  m i s s e s  w h i c h  h a d
been made by other people.
Importantly, these interviews identified the same types
of medication errors as did the more resource-intensive
record review method. This method therefore offers notSavage et al. BMC Health Services Research 2010, 10:135
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only an evaluation tool but also another way of auditing
current medication safety problems, which could be used
to supplement information from anonymous reporting
schemes.
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